| RRC ID |
78689
|
| 著者 |
Liu C, Imai M, Edahiro Y, Mano S, Takei H, Nudejima M, Kurose A, Morishita S, Ando M, Tsuneda S, Araki M, Komatsu N.
|
| タイトル |
Establishment of isogenic induced pluripotent stem cells with or without pathogenic mutation for understanding the pathogenesis of myeloproliferative neoplasms.
|
| ジャーナル |
Exp Hematol
|
| Abstract |
Identification and functional characterization of disease-associated genetic traits are crucial for understanding the pathogenesis of hematologic malignancies. Various in vitro and in vivo models, including cell lines, primary cells, and animal models, have been established to examine these genetic alterations. However, their nonphysiologic conditions, diverse genetic backgrounds, and species-specific differences often limit data interpretation. To evaluate somatic mutations in myeloproliferative neoplasms (MPNs), we used CRISPR/Cas9 combined with the piggyBac transposon system to establish isogenic induced pluripotent stem (iPS) cell lines with or without JAK2V617F mutation, a driver mutation of MPNs. We induced hematopoietic stem/progenitor cells (HSPCs) from these iPS cells and observed phenotypic differences during hematopoiesis using fluorescence-activated cell sorting analysis. HSPCs with pathogenic mutations exhibited cell-autonomous erythropoiesis and megakaryopoiesis, which are hallmarks in the bone marrow of patients with MPNs. Furthermore, we used these HSPCs as a model to validate therapeutic compounds and showed that interferon alpha selectively inhibited erythropoiesis and megakaryopoiesis in mutant HSPCs. These results demonstrate that genome editing is feasible for establishing isogenic iPS cells, studying genetic elements to understand the pathogenesis of MPNs, and evaluating therapeutic compounds against MPNs.
|
| 巻・号 |
118
|
| ページ |
12-20
|
| 公開日 |
2023-2-1
|
| DOI |
10.1016/j.exphem.2022.11.005
|
| PII |
S0301-472X(22)00809-8
|
| PMID |
36511286
|
| MeSH |
Animals
Erythropoiesis
Hematologic Neoplasms* / metabolism
Induced Pluripotent Stem Cells* / metabolism
Janus Kinase 2 / genetics
Mutation
Myeloproliferative Disorders* / pathology
|
| リソース情報 |
| ヒト・動物細胞 |
10T1/2(RCB0247) |
